Trial intelligence / Profile preview

Intranasal dexmedetomidine for preoperative sedation in general anesthesia

CTR20200815Phase 3Completed

Sponsor
Hengrui Therapeutics
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine in preoperative anxiety, None, sponsored by Hengrui Therapeutics. Started May 2020; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

preoperative anxiety

Beyond the preview

Go deeper on CTR20200815.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20200815.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call